-
Share
2,071 Posts.
443
10/02/23
09:31
Share
Rene- "It indicates to me that regulatory discussions on paxalisib in DIPG can happen far sooner than at the end of the combo DIPG trial."
I still feel approval (provisional in combo with ONC201) will come before it does for GBM, despite GBM trial's long "head start".
If that happens, we won't have to worry about where additional funding will originate. (I'm compelled to mention that every now and then.)